CGC-11047

PG-11047 · Progen Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CGC-11047, covering 2012-02-27 to 2015-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer [Phase 2]